---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-097561"
form_type: "8-K"
ticker: "ELUT"
cik: "0001708527"
company_name: "ELUTIA INC."
filed_at: "2025-10-07T23:59:59+00:00"
generated_at: "2026-05-17T04:27:49.566314+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Elutia closes $88M sale of BioEnvelope business to Boston Scientific; pivots to NXT-41x

## Summary
- Closed sale of CIED/BioEnvelope business to Boston Scientific for $88M cash; $80.3M paid at closing, $8M escrowed for 12 months.
- Used $27.8M of proceeds to fully repay and terminate SWK Credit Agreement (principal $24.5M plus fees).
- Amended Ligand royalty agreement: paid $1.1M accrued royalties; Ligand consented to sale and released security interest in CIED assets.
- Company will focus on NXT-41x drug-eluting biomatrix for breast reconstruction; expects launch first half 2027.
- Pro forma cash balance ~$57M; Device Protection Business reported as discontinued operations in future filings.

## SEC filing metadata
- accession: 0001104659-25-097561
- form_type: 8-K
- ticker: ELUT
- cik: 0001708527
- company_name: ELUTIA INC.
- filed_at: 2025-10-07T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 2.01, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1708527/000110465925097561/0001104659-25-097561-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1708527/000110465925097561/tm2528122d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-097561
- JSON: https://secwatch.observer/filing/0001104659-25-097561.json
- Plain text: https://secwatch.observer/filing/0001104659-25-097561.txt

## Source-grounded claims
- claim_id: 73a2c0837b8be4648661ecb49a57a9c20a7059a6
  claim: ELUTIA INC. completed a disposition involving Boston Scientific Corporation and Cardiac Pacemakers, Inc. (closed 2025-10-01).
  evidence_excerpt: On October 1, 2025, the parties completed the sale of the CIED Business.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1708527/000110465925097561/0001104659-25-097561-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.